Preclinical model showsLigilactobacillus salivarius improves behavior and metabolism in depression, suggesting probiotic benefits.
Ligilactobacillus salivarius CECT 30632 improved behavioral outcomes, enhanced antioxidant defenses, and modulated tryptophan metabolism in a rat model of CMS. These findings support its potential as a probiotic intervention for depression.
No takes yet. Share an insight, caveat, or question.
Martín-Hernández et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: